Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome

Human Molecular Genetics

Volumn 20, Issue 16, 2011, Pages 3138-3150

  Layman, Wanda S ^a   Hurd, Elizabeth A ^a   Martin, Donna M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMODOMAIN HELICASE DNA BINDING PROTEIN 7; DNA BINDING PROTEIN; FOLLITROPIN; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN RECEPTOR; LUTEINIZING HORMONE; TRANSCRIPTION FACTOR OTX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; ESTRUS CYCLE; FEMALE; GENE EXPRESSION; GENE MUTATION; HYPOPHYSIS; HYPOTHALAMUS; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PUBERTY; REPRODUCTION; SYNDROME CHARGE; VAGINA DISEASE;

ANIMALS; CELL COUNT; CELL PROLIFERATION; CHARGE SYNDROME; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; ESTROUS CYCLE; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GONADOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; MICE; NEUROGENESIS; NEURONS; NOSE; OLFACTORY BULB; PITUITARY GLAND; PUBERTY; REPRODUCTION;

MUS;

EID: 79960802234     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr216     Document Type: Article

References (109)

1. Harris, J., Robert, E. and Kallen, B. (1997) Epidemiology of choanal atresia with special reference to the CHARGE association. Pediatrics, 99, 363-367.
2. Issekutz, K.A., Graham, J.M. Jr, Prasad, C., Smith, I.M. and Blake, K.D. (2005) An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study. Am. J. Med. Genet. A, 133, 309-317.
3. Kallen, K., Robert, E., Mastroiacovo, P., Castilla, E.E. and Kallen, B. (1999) CHARGE Association in newborns: a registry-based study. Teratology, 60, 334-343.
4. Hall, B.D. (1979) Choanal atresia and associated multiple anomalies. J. Pediatr., 95, 395-398.
5. Asakura, Y., Toyota, Y., Muroya, K., Kurosawa, K., Fujita, K., Aida, N., Kawame, H., Kosaki, K. and Adachi, M. (2008) Endocrine and radiological studies in patients with molecularly confirmed CHARGE syndrome. J. Clin. Endocrinol. Metab., 93, 920-924.
6. Jongmans, M.C., Admiraal, R.J., van der Donk, K.P., Vissers, L.E., Baas, A.F., Kapusta, L., van Hagen, J.M., Donnai, D., de Ravel, T.J., Veltman, J.A. et al. (2006) CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J. Med. Genet., 43, 306-314.
7. Jongmans, M.C., van Ravenswaaij-Arts, C.M., Pitteloud, N., Ogata, T., Sato, N., Claahsen-van der Grinten, H.L., van der Donk, K., Seminara, S., Bergman, J.E., Brunner, H.G. et al. (2009) CHD7 mutations in patients initially diagnosed with Kallmann syndrome-the clinical overlap with CHARGE syndrome. Clin. Genet., 75, 65-71.
8. Kim, H.G., Kurth, I., Lan, F., Meliciani, I., Wenzel, W., Eom, S.H., Kang, G.B., Rosenberger, G., Tekin, M., Ozata, M. et al. (2008) Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet., 83, 511-519.
9. Lalani, S.R., Safiullah, A.M., Fernbach, S.D., Harutyunyan, K.G., Thaller, C., Peterson, L.E., McPherson, J.D., Gibbs, R.A., White, L.D., Hefner, M. et al. (2006) Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am. J. Hum. Genet., 78, 303-314.
10. Ogata, T., Fujiwara, I., Ogawa, E., Sato, N., Udaka, T. and Kosaki, K. (2006) Kallmann syndrome phenotype in a female patient with CHARGE syndrome and CHD7 mutation. Endocr. J., 53, 741-743.
11. Pinto, G., Abadie, V., Mesnage, R., Blustajn, J., Cabrol, S., Amiel, J., Hertz-Pannier, L., Bertrand, A.M., Lyonnet, S., Rappaport, R. et al. (2005) CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. J. Clin. Endocrinol. Metab., 90, 5621-5626.
12. Zentner, G.E., Layman, W.S., Martin, D.M. and Scacheri, P.C. (2010) Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am. J. Med. Genet. A, 152A, 674-686.
13. Camper, S., Suh, H., Raetzman, L., Douglas, K., Cushman, L., Nasonkin, I., Burrows, H., Gage, P. and Martin, D. (2002) In Rossant, J. and Tam, P. (eds), Mouse Development Patterning, Morphogenesis, and Organogenesis. Academic Press, San Diego, pp. 499-518.
14. Krsmanovic, L.Z., Hu, L., Leung, P.K., Feng, H. and Catt, K.J. (2009) The hypothalamic GnRH pulse generator: multiple regulatory mechanisms. Trends Endocrinol. Metab., 20, 402-408.
15. Maffucci, J.A. and Gore, A.C. (2009) Chapter 2: hypothalamic neural systems controlling the female reproductive life cycle gonadotropin-releasing hormone, glutamate, and GABA. Int. Rev. Cell Mol. Biol., 274, 69-127.
16. Wray, S. (2002) Development of gonadotropin-releasing hormone-1 neurons. Front. Neuroendocrinol., 23, 292-316.
17. Chu, Z., Andrade, J., Shupnik, M.A. and Moenter, S.M. (2009) Differential regulation of gonadotropin-releasing hormone neuron activity and membrane properties by acutely applied estradiol: dependence on dose and estrogen receptor subtype. J. Neurosci., 29, 5616-5627.
18. Kelley, C.G., Lavorgna, G., Clark, M.E., Boncinelli, E. and Mellon, P.L. (2000) The Otx2 homeoprotein regulates expression from the gonadotropin-releasing hormone proximal promoter. Mol. Endocrinol., 14, 1246-1256.
19. Larder, R. and Mellon, P.L. (2009) Otx2 induction of the gonadotropin-releasing hormone promoter is modulated by direct interactions with Grg co-repressors. J. Biol. Chem., 284, 16966-16978.
20. Dateki, S., Kosaka, K., Hasegawa, K., Tanaka, H., Azuma, N., Yokoya, S., Muroya, K., Adachi, M., Tajima, T., Motomura, K. et al. (2010) Heterozygous orthodenticle homeobox 2 mutations are associated with variable pituitary phenotype. J. Clin. Endocrinol. Metab., 95, 756-764.
21. Omodei, D., Acampora, D., Mancuso, P., Prakash, N., Di Giovannantonio, L.G., Wurst, W. and Simeone, A. (2008) Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon. Development, 135, 3459-3470.
22. Vernay, B., Koch, M., Vaccarino, F., Briscoe, J., Simeone, A., Kageyama, R. and Ang, S.L. (2005) Otx2 regulates subtype specification and neurogenesis in the midbrain. J. Neurosci., 25, 4856-4867.
23. Kawauchi, S., Shou, J., Santos, R., Hebert, J.M., McConnell, S.K., Mason, I. and Calof, A.L. (2005) Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in the mouse. Development, 132, 5211-5223.
24. Hebert, J.M., Lin, M., Partanen, J., Rossant, J. and McConnell, S.K. (2003) FGF signaling through FGFR1 is required for olfactory bulb morphogenesis. Development, 130, 1101-1111.
25. Hsu, P., Yu, F., Feron, F., Pickles, J.O., Sneesby, K. and Mackay-Sim, A. (2001) Basic fibroblast growth factor and fibroblast growth factor receptors in adult olfactory epithelium. Brain Res., 896, 188-197.
26. Chung, W.C., Moyle, S.S. and Tsai, P.S. (2008) Fibroblast growth factor 8 signaling through fibroblast growth factor receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons. Endocrinology, 149, 4997-5003.
27. Falardeau, J., Chung, W.C., Beenken, A., Raivio, T., Plummer L., Sidis, Y., Jacobson-Dickman, E.E., Eliseenkova, A.V., Ma, J., Dwyer, A. et al. (2008) Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest., 118, 2822-2831.
28. Tsai, P.S., Moenter, S.M., Postigo, H.R., El Majdoubi, M., Pak, T.R., Gill, J.C., Paruthiyil, S., Werner, S. and Weiner, R.I. (2005) Targeted expression of a dominant-negative fibroblast growth factor (FGF) receptor in gonadotropin-releasing hormone (GnRH) neurons reduces FGF responsiveness and the size of GnRH neuronal population. Mol. Endocrinol., 19, 225-236.
29. Layman, W.S., McEwen, D.P., Beyer, L.A., Lalani, S.R., Fernbach, S.D., Oh, E., Swaroop, A., Hegg, C.C., Raphael, Y., Martens, J.R. et al. (2009) Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum. Mol. Genet., 18, 1909-1923.
30. Hurd, E.A., Capers, P.L., Blauwkamp, M.N., Adams, M.E., Raphael, Y., Poucher, H.K. and Martin, D.M. (2007) Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm. Genome, 18, 94-104.
31. Sanlaville, D., Etchevers, H.C., Gonzales, M., Martinovic, J., Clement-Ziza, M., Delezoide, A.L., Aubry, M.C., Pelet, A., Chemouny, S., Cruaud, C. et al. (2006) Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J. Med. Genet., 43, 211-217.
32. Wray, S., Grant, P. and Gainer, H. (1989) Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc. Natl Acad. Sci. USA, 86, 8132-8136.
33. Becker, P.B. and Horz, W. (2002) ATP-dependent nucleosome remodeling. Annu. Rev. Biochem., 71, 247-273.
34. Eberharter, A. and Becker, P.B. (2004) ATP-dependent nucleosome remodelling: factors and functions. J. Cell Sci., 117, 3707-3711.
35. Lusser, A. and Kadonaga, J.T. (2003) Chromatin remodeling by ATP-dependent molecular machines. Bioessays, 25, 1192-1200.
36. Narlikar, G.J., Fan, H.Y. and Kingston, R.E. (2002) Cooperation between complexes that regulate chromatin structure and transcription. Cell, 108, 475-487.
37. Smith, C.L. and Peterson, C.L. (2005) ATP-dependent chromatin remodeling. Curr. Top. Dev. Biol., 65, 115-148.
38. Bergman, J.E., Bosman, E.A., van Ravenswaaij-Arts, C.M. and Steel, K.P. (2009) Study of smell and reproductive organs in a mouse model for CHARGE syndrome. Eur. J. Hum. Genet., 18, 171-177.
39. Bosman, E.A., Penn, A.C., Ambrose, J.C., Kettleborough, R., Stemple, D.L. and Steel, K.P. (2005) Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum. Mol. Genet., 14, 3463-3476.
40. Nelson, J.F., Karelus, K., Felicio, L.S. and Johnson, T.E. (1990) Genetic influences on the timing of puberty in mice. Biol. Reprod., 42, 649-655.
41. Lee, J.M., Appugliese, D., Kaciroti, N., Corwyn, R.F., Bradley, R.H. and Lumeng, J.C. (2007) Weight status in young girls and the onset of puberty. Pediatrics, 119, e624-e630.
42. Ahima, R.S., Dushay, J., Flier, S.N., Prabakaran, D. and Flier, J.S. (1997) Leptin accelerates the onset of puberty in normal female mice. J. Clin. Invest., 99, 391-395.
43. Foster, D.L., Ebling, F.J., Micka, A.F., Vannerson, L.A., Bucholtz, D.C., Wood, R.I., Suttie, J.M. and Fenner, D.E. (1989) Metabolic interfaces between growth and reproduction. I. Nutritional modulation of gonadotropin, prolactin, and growth hormone secretion in the growth-limited female lamb. Endocrinology, 125, 342-350.
44. Frisch, R.E. and McArthur, J.W. (1974) Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science, 185, 949-951.
45. Kennedy, G.C. (1969) Interactions between feeding behavior and hormones during growth. Ann. N. Y. Acad. Sci., 157, 1049-1061.
46. Budak, E., Fernandez Sanchez, M., Bellver, J., Cervero, A., Simon, C. and Pellicer, A. (2006) Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil. Steril., 85, 1563-1581.
47. Plum, L., Schubert, M. and Bruning, J.C. (2005) The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab., 16, 59-65.
48. Schneider, J.E. (2004) Energy balance and reproduction. Physiol. Behav., 81, 289-317.
49. Bruning, J.C., Gautam, D., Burks, D.J., Gillette, J., Schubert, M., Orban, P.C., Klein, R., Krone, W., Muller-Wieland, D. and Kahn, C.R. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science, 289, 2122-2125.
50. Chehab, F.F., Lim, M.E. and Lu, R. (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet., 12, 318-320.
51. He, D., Funabashi, T., Sano, A., Uemura, T., Minaguchi, H. and Kimura, F. (1999) Effects of glucose and related substrates on the recovery of the electrical activity of gonadotropin-releasing hormone pulse generator which is decreased by insulin-induced hypoglycemia in the estrogen-primed ovariectomized rat. Brain Res., 820, 71-76.
52. Hiney, J.K., Srivastava, V., Nyberg, C.L., Ojeda, S.R. and Dees, W.L. (1996) Insulin-like growth factor I of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology, 137, 3717-3728.
53. Longo, K.M., Sun, Y. and Gore, A.C. (1998) Insulin-like growth factor-I effects on gonadotropin-releasing hormone biosynthesis in GT1-7 cells. Endocrinology, 139, 1125-1132.
54. Mounzih, K., Lu, R. and Chehab, F.F. (1997) Leptin treatment rescues the sterility of genetically obese ob/ob males. Endocrinology, 138, 1190-1193.
55. Schneider, J.E. and Wade, G.N. (1989) Availability of metabolic fuels controls estrous cyclicity of Syrian hamsters. Science, 244, 1326-1328.
56. Luque, R.M., Park, S. and Kineman, R.D. (2007) Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone. Endocrinology, 148, 300-309.
57. Staley, K. and Scharfman, H. (2005) A woman's prerogative. Nat. Neurosci., 8, 697-699.
58. Kumar, T.R., Wang, Y., Lu, N. and Matzuk, M.M. (1997) Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet., 15, 201-204.
59. Layman, L.C. and McDonough, P.G. (2000) Mutations of follicle stimulating hormone-beta and its receptor in human and mouse: genotype/phenotype. Mol. Cell Endocrinol., 161, 9-17.
60. Layman, L.C., Porto, A.L., Xie, J., da Motta, L.A., da Motta, L.D., Weiser, W. and Sluss, P.M. (2002) FSH beta gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J. Clin. Endocrinol. Metab., 87, 3702-3707.
61. Phillip, M., Arbelle, J.E., Segev, Y. and Parvari, R. (1998) Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N. Engl. J. Med., 338, 1729-1732.
62. Lamba, P., Santos, M.M., Philips, D.P. and Bernard, D.J. (2006) Acute regulation of murine follicle-stimulating hormone beta subunit transcription by activin A. J. Mol. Endocrinol., 36, 201-220.
63. Weiss, J., Guendner, M.J., Halvorson, L.M. and Jameson, J.L. (1995) Transcriptional activation of the follicle-stimulating hormone beta-subunit gene by activin. Endocrinology, 136, 1885-1891.
64. Wen, S., Ai, W., Alim, Z. and Boehm, U. (2010) Embryonic gonadotropin-releasing hormone signaling is necessary for maturation of the male reproductive axis. Proc. Natl Acad. Sci. USA, 152, 1515-1526.
65. Pask, A.J., Kanasaki, H., Kaiser, U.B., Conn, P.M., Janovick, J.A., Stockton, D.W., Hess, D.L., Justice, M.J. and Behringer, R.R. (2005) A novel mouse model of hypogonadotrophic hypogonadism: N-ethyl-N-nitrosourea-induced gonadotropin-releasing hormone receptor gene mutation. Mol. Endocrinol., 19, 972-981.
66. Wu, S., Wilson, M.D., Busby, E.R., Isaac, E.R. and Sherwood, N.M. (2010) Disruption of the single copy gonadotropin-releasing hormone receptor in mice by gene trap: severe reduction of reproductive organs and functions in developing and adult mice. Endocrinology, 151, 1142-1152.
67. Messager, S., Chatzidaki, E.E., Ma, D., Hendrick, A.G., Zahn, D., Dixon, J., Thresher, R.R., Malinge, I., Lomet, D., Carlton, M.B. et al. (2005) Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc. Natl Acad. Sci. USA, 102, 1761-1766.
68. Gill, J.C., Wadas, B., Chen, P., Portillo, W., Reyna, A., Jorgensen, E., Mani, S., Schwarting, G.A., Moenter, S.M., Tobet, S. et al. (2008) The gonadotropin-releasing hormone (GnRH) neuronal population is normal in size and distribution in GnRH-deficient and GnRH receptor-mutant hypogonadal mice. Endocrinology, 149, 4596-4604.
69. Sofianos, Z.D., Katsila, T., Kostomitsopoulos, N., Balafas, V., Matsoukas, J., Tselios, T. and Tamvakopoulos, C. (2008) In vivo evaluation and in vitro metabolism of leuprolide in mice-mass spectrometry-based biomarker measurement for efficacy and toxicity. J. Mass Spectrom., 43, 1381-1392.
70. Yamazaki, I. and Okada, H. (1980) A radioimmunoassay for a highly active luteinizing hormone-releasing hormone analogue and relation between the serum level of the analogue and that of gonadotropin. Endocrinol. Jpn, 27, 593-605.
71. Danforth, D.R., Arbogast, L.K. and Friedman, C.I. (2005) Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil. Steril., 83, 1333-1338.
72. Ljungqvist, A., Feng, D.M., Hook, W., Shen, Z.X., Bowers, C. and Folkers, K. (1988) Antide and related antagonists of luteinizing hormone release with long action and oral activity. Proc. Natl Acad. Sci. USA, 85, 8236-8240.
73. Bennett-Clarke, C. and Joseph, S.A. (1982) Immunocytochemical distribution of LHRH neurons and processes in the rat: hypothalamic and extrahypothalamic locations. Cell Tissue Res., 221, 493-504.
74. Wierman, M.E., Kiseljak-Vassiliades, K. and Tobet, S. (2010) Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Front. Neuroendocrinol., 32, 43-52.
75. Colledge, W.H., Mei, H. and Tassigny, X.D. (2010) Mouse models to study the central regulation of puberty. Mol. Cell Endocrinol., 324, 12-20.
76. Matsumoto, S., Yamazaki, C., Masumoto, K.H., Nagano, M., Naito, M., Soga, T., Hiyama, H., Matsumoto, M., Takasaki, J., Kamohara, M. et al. (2006) Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc. Natl Acad. Sci. USA, 103, 4140-4145.
77. Gamble, J.A., Karunadasa, D.K., Pape, J.R., Skynner, M.J., Todman, M.G., Bicknell, R.J., Allen, J.P. and Herbison, A.E. (2005) Disruption of ephrin signaling associates with disordered axophilic migration of the gonadotropin-releasing hormone neurons. J. Neurosci., 25, 3142-3150.
78. Cogliati, T., Delgado-Romero, P., Norwitz, E.R., Guduric-Fuchs, J., Kaiser, U.B., Wray, S. and Kirsch, I.R. (2007) Pubertal impairment in Nhlh2 null mice is associated with hypothalamic and pituitary deficiencies. Mol. Endocrinol., 21, 3013-3027.
79. Compagnucci, C., Fish, J.L., Schwark, M., Tarabykin, V. and Depew, M.J. (2011) Pax6 regulates craniofacial form through its control of an essential cephalic ectodermal patterning center. Genesis, 49, 307-325.
80. Kaiser, U.B., Jakubowiak, A., Steinberger, A. and Chin, W.W. (1993) Regulation of rat pituitary gonadotropin-releasing hormone receptor mRNA levels in vivo and in vitro. Endocrinology, 133, 931-934.
81. White, B.R., Duval, D.L., Mulvaney, J.M., Roberson, M.S. and Clay, C.M. (1999) Homologous regulation of the gonadotropin-releasing hormone receptor gene is partially mediated by protein kinase C activation of an activator protein-1 element. Mol. Endocrinol., 13, 566-577.
82. Yasin, M., Dalkin, A.C., Haisenleder, D.J., Kerrigan, J.R. and Marshall, J.C. (1995) Gonadotropin-releasing hormone (GnRH) pulse pattern regulates GnRH receptor gene expression: augmentation by estradiol. Endocrinology, 136, 1559-1564.
83. Hurd, E.A., Poucher, H.K., Cheng, K., Raphael, Y. and Martin, D.M. (2010) The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear. Development, 137, 3139-3150.
84. Schnetz, M.P., Handoko, L., Akhtar-Zaidi, B., Bartels, C.F., Pereira, C.F., Fisher, A.G., Adams, D.J., Flicek, P., Crawford, G.E., Laframboise, T. et al. (2010) CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet., 6, e1001023.
85. Bajpai, R., Chen, D.A., Rada-Iglesias, A., Zhang, J., Xiong, Y., Helms, J., Chang, C.P., Zhao, Y., Swigut, T. and Wysocka, J. (2010) CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature, 463, 958-962.
86. Takada, I., Mihara, M., Suzawa, M., Ohtake, F., Kobayashi, S., Igarashi, M., Youn, M.Y., Takeyama, K., Nakamura, T., Mezaki, Y. et al. (2007) A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat. Cell Biol., 9, 1273-1285.
87. Srinivasan, S., Dorighi, K.M. and Tamkun, J.W. (2008) Drosophila Kismet regulates histone H3 lysine 27 methylation and early elongation by RNA polymerase II. PLoS Genet., 4, e1000217.
88. Cattanach, B.M., Iddon, C.A., Charlton, H.M., Chiappa, S.A. and Fink, G. (1977) Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature, 269, 338-340.
89. Ho, L. and Crabtree, G.R. (2010) Chromatin remodelling during development. Nature, 463, 474-484.
90. Peretto, P., Cummings, D., Modena, C., Behrens, M., Venkatraman, G., Fasolo, A. and Margolis, F.L. (2002) BMP mRNA and protein expression in the developing mouse olfactory system. J. Comp. Neurol., 451, 267-278.
91. Peretto, P., Dati, C., De Marchis, S., Kim, H.H., Ukhanova, M., Fasolo, A. and Margolis, F.L. (2004) Expression of the secreted factors noggin and bone morphogenetic proteins in the subependymal layer and olfactory bulb of the adult mouse brain. Neuroscience, 128, 685-696.
92. Cate, H.S., Sabo, J.K., Merlo, D., Kemper, D., Aumann, T.D., Robinson, J., Merson, T.D., Emery, B., Perreau, V.M. and Kilpatrick, T.J. (2010) Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination. J. Neurochem., 115, 11-22.
93. Kang, K. and Song, M.R. (2010) Diverse FGF receptor signaling controls astrocyte specification and proliferation. Biochem. Biophys. Res. Commun., 395, 324-329.
94. Gonzalez-Quevedo, R., Lee, Y., Poss, K.D. and Wilkinson, D.G. (2010) Neuronal regulation of the spatial patterning of neurogenesis. Dev. Cell, 18, 136-147.
95. Maier, E., von Hofsten, J., Nord, H., Fernandes, M., Paek, H., Hebert, J.M. and Gunhaga, L. (2010) Opposing Fgf and Bmp activities regulate the specification of olfactory sensory and respiratory epithelial cell fates. Development, 137, 1601-1611.
96. Shou, J., Murray, R.C., Rim, P.C. and Calof, A.L. (2000) Opposing effects of bone morphogenetic proteins on neuron production and survival in the olfactory receptor neuron lineage. Development, 127, 5403-5413.
97. Shou, J., Rim, P.C. and Calof, A.L. (1999) BMPs inhibit neurogenesis by a mechanism involving degradation of a transcription factor. Nat. Neurosci., 2, 339-345.
98. Bonaguidi, M.A., Peng, C.Y., McGuire, T., Falciglia, G., Gobeske, K.T., Czeisler, C. and Kessler, J.A. (2008) Noggin expands neural stem cells in the adult hippocampus. J. Neurosci., 28, 9194-9204.
99. Calof, A.L., Bonnin, A., Crocker, C., Kawauchi, S., Murray, R.C., Shou, J. and Wu, H.H. (2002) Progenitor cells of the olfactory receptor neuron lineage. Microsc. Res. Tech., 58, 176-188.
100. Colak, D., Mori, T., Brill, M.S., Pfeifer, A., Falk, S., Deng, C., Monteiro, R., Mummery, C., Sommer, L. and Gotz, M. (2008) Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells. J. Neurosci., 28, 434-446.
101. Garcia-Gonzalez, D., Clemente, D., Coelho, M., Esteban, P.F., Soussi-Yanicostas, N. and de Castro, F. (2010) Dynamic roles of FGF-2 and Anosmin-1 in the migration of neuronal precursors from the subventricular zone during pre- and postnatal development. Exp. Neurol., 222, 285-295.
102. Vissers, L.E., van Ravenswaaij, C.M., Admiraal, R., Hurst, J.A., de Vries, B.B., Janssen, I.M., van der Vliet, W.A., Huys, E.H., de Jong, P.J., Hamel, B.C. et al. (2004) Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat. Genet., 36, 955-957.
103. Wyatt, A., Bakrania, P., Bunyan, D.J., Osborne, R.J., Crolla, J.A., Salt, A., Ayuso, C., Newbury-Ecob, R., Abou-Rayyah, Y., Collin, J.R. et al. (2008) Novel heterozygous OTX2 mutations and whole gene deletions in anophthalmia, microphthalmia and coloboma. Hum. Mutat., 29, E278-E283.
104. Dateki, S., Fukami, M., Sato, N., Muroya, K., Adachi, M. and Ogata, T. (2008) OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters. J. Clin. Endocrinol. Metab., 93, 3697-3702.
105. Fallest, P.C., Trader, G.L., Darrow, J.M. and Shupnik, M.A. (1995) Regulation of rat luteinizing hormone beta gene expression in transgenic mice by steroids and a gonadotropin-releasing hormone antagonist. Biol. Reprod., 53, 103-109.
106. Haavisto, A.M., Pettersson, K., Bergendahl, M., Perheentupa, A., Roser, J.F. and Huhtaniemi, I. (1993) A supersensitive immunofluorometric assay for rat luteinizing hormone. Endocrinology, 132, 1687-1691.
107. Matteri, R.L., Roser, J.F., Baldwin, D.M., Lipovetsky, V. and Papkoff, H. (1987) Characterization of a monoclonal antibody which detects luteinizing hormone from diverse mammalian species. Domest. Anim. Endocrinol., 4, 157-165.
108. Gay, V.L., Midgley, A.R. Jr and Niswender, G.D. (1970) Patterns of gonadotrophin secretion associated with ovulation. Fed. Proc., 29, 1880-1887.
109. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.